Biocryst Pharmaceuticals Inc.

NASDAQ: BCRX    
Share price (5/3/24): $4.48    
Market cap (5/3/24): $924 million
Search in Documents
Key Exhibits
External Links
8 Biocryst Pharmaceuticals Inc. Expert Interviews, now on BamSEC.
 Powered by Tegus.

Indentures Filter

EX-4.8
from S-3ASR 45 pages Biocryst Pharmaceuticals, Inc. Debt Securities Indenture Dated as of [___] U.S. Bank Trust Company, National Association, as Trustee
12/34/56
EX-4.1
from 10-K 2 pages Description of Securities
12/34/56
EX-4.1
from 8-K 10 pages Biocryst Pharmaceuticals, Inc. Form of Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.9
from S-3 45 pages Biocryst Pharmaceuticals, Inc. Debt Securities Indenture Dated as of [___] U.S. Bank National Association., as Trustee
12/34/56
EX-4.1
from 10-K 2 pages Common Stock
12/34/56
EX-4.1
from 8-K 11 pages Biocryst Pharmaceuticals, Inc. Form of Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.3
from 10-Q 140 pages Indenture Dated as of March 9, 2011 by and Between Jpr Royalty Sub LLC, a Delaware Limited Liability Company, as Issuer of the Notes Described Herein, and U.S. Bank National Association, a National Banking Association, as Initial Trustee of the Notes Described Herein
12/34/56
EX-4.7
from S-3 2 pages Cusip 09058v 10 3
12/34/56
EX-4.5
from S-3 3 pages Specimen Certificate for Registrant's Common Stock
12/34/56
EX-4.2
from 10-Q 2 pages Amendment of Biocryst Rights Agreement
12/34/56
EX-4.2
from 8-K 14 pages Form of Warrant
12/34/56
EX-4.1
from 8-K 39 pages Stock and Warrant Purchase Agreement
12/34/56
EX-4.2
from 8-K 6 pages Nomination and Observer Agreement
12/34/56
EX-4.1
from 8-K 22 pages Stock Purchase Agreement
12/34/56
EX-4.1
from 8-K 11 pages Stock Purchase Agreement
12/34/56
EX-4
from 8-K ~50 pages Rights Agreement by and Between Biocryst Pharmaceuticals, Inc. and American Stock Transfer & Trust Company, as Rights Agent Dated as of June 17, 2002
12/34/56